Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

SRR12475165

7c407e99-5fd8-5be0-85e4-bd9051e3fbde

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • OXIDATIVE_PHOSPHORYLATION+0.270
  • MYC_TARGETS_V1+0.210
  • UNFOLDED_PROTEIN_RESPONSE+0.100
  • DNA_REPAIR+0.090
  • PROTEIN_SECRETION+0.050
  • FATTY_ACID_METABOLISM+0.020
  • KRAS_SIGNALING_DN+0.000
  • MYC_TARGETS_V2+0.000
  • BILE_ACID_METABOLISM-0.030
  • GLYCOLYSIS-0.050

Top 10 suppressed

  • ANGIOGENESIS-0.620
  • EPITHELIAL_MESENCHYMAL_TRANSITION-0.570
  • TGF_BETA_SIGNALING-0.430
  • APICAL_SURFACE-0.400
  • CHOLESTEROL_HOMEOSTASIS-0.380
  • COAGULATION-0.370
  • INTERFERON_ALPHA_RESPONSE-0.370
  • NOTCH_SIGNALING-0.370
  • APICAL_JUNCTION-0.360
  • MYOGENESIS-0.350

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

3 twins match this tumor's tissue · 7 come from a different tissue of origin ← cross-tissue dominant

#SampleCancer typeSubtypecos similarity
1R16
bladder-landscape@3
0.889
2SRR1429307
brain-umap@2
GTEX0.884
3SRR1456841
brain-umap@2
GTEX0.883
4SRR1385036
brain-umap@2
GTEX0.880
5SRR1069188
brain-umap@2
GTEX0.879
6425dc52d-fb29-45d5-8d94-aab524136a83
colon-landscapes@1
0.879
7SRR1351325
brain-umap@2
GTEX0.879
8SRR1499442
brain-umap@2
GTEX0.878
9SRR1340420
brain-umap@2
GTEX0.876
10SRR8518194
breast-umap@18
D0.875

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 6 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
OXIDATIVE_PHOSPHORYLATION0.270Remibrutinib— uncovered
MYC_TARGETS_V10.210Inavolisib— uncovered
UNFOLDED_PROTEIN_RESPONSE0.100Idelalisib— uncovered
DNA_REPAIR0.090Idelalisib— uncovered
PROTEIN_SECRETION0.050Remibrutinib— uncovered
FATTY_ACID_METABOLISM0.020Inavolisib— uncovered